Total Payments
$44,139
2024 Payments
$117.01
Companies
10
Transactions
127
Medicare Patients
3,761
Medicare Billing
$592,592

Payment Breakdown by Category

Other$34,287 (77.7%)
Travel$5,383 (12.2%)
Education$2,332 (5.3%)
Food & Beverage$2,137 (4.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $22,187 13 50.3%
Honoraria $12,100 5 27.4%
Travel and Lodging $5,383 13 12.2%
Education $2,332 64 5.3%
Food and Beverage $2,137 32 4.8%

Top Paying Companies

Company Total Records Latest Year
Alexion Pharmaceuticals, Inc. $43,521 114 $0 (2020)
AstraZeneca Pharmaceuticals LP $142.15 2 $0 (2024)
Amgen Inc. $137.33 2 $0 (2024)
Vifor Pharma, Inc. $124.99 1 $0 (2023)
BAXTER HEALTHCARE $92.43 1 $0 (2017)
AKEBIA THERAPEUTICS INC $51.00 3 $0 (2020)
Otsuka America Pharmaceutical, Inc. $29.98 1 $0 (2024)
Travere Therapeutics, Inc. $23.74 1 $0 (2024)
Janssen Pharmaceuticals, Inc $15.13 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $117.01 5 Amgen Inc. ($31.02)
2023 $250.00 2 AstraZeneca Pharmaceuticals LP ($125.01)
2020 $2,414 5 Alexion Pharmaceuticals, Inc. ($2,363)
2019 $4,808 7 Alexion Pharmaceuticals, Inc. ($4,700)
2018 $10,050 13 Alexion Pharmaceuticals, Inc. ($10,050)
2017 $26,500 95 Alexion Pharmaceuticals, Inc. ($26,408)

All Payment Transactions

127 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/02/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $31.02 General
Category: Inflammation
10/15/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $29.98 General
Category: NEPHROLOGY
10/04/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $17.14 General
Category: Cardiovascular and Metabolism
07/02/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $15.13 General
Category: Cardiovascular & Metabolism
04/26/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $23.74 General
09/28/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $125.01 General
Category: Cardiovascular and Metabolism
03/29/2023 Vifor Pharma, Inc. Veltassa (Drug), Korsuva Food and Beverage In-kind items and services $124.99 General
Category: Hyperkalemia
11/09/2020 AKEBIA THERAPEUTICS INC AURYXIA (Drug) Food and Beverage In-kind items and services $16.65 General
Category: NEPHROLOGY
10/06/2020 Alexion Pharmaceuticals, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,050.00 General
09/16/2020 AKEBIA THERAPEUTICS INC AURYXIA (Drug) Food and Beverage In-kind items and services $22.74 General
Category: NEPHROLOGY
04/28/2020 AKEBIA THERAPEUTICS INC AURYXIA (Drug) Food and Beverage In-kind items and services $11.61 General
Category: NEPHROLOGY
04/09/2020 Alexion Pharmaceuticals, Inc. Ultomiris (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,312.50 General
Category: Immunology
12/10/2019 Alexion Pharmaceuticals, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $750.00 General
11/21/2019 Alexion Pharmaceuticals, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $750.00 General
10/15/2019 Alexion Pharmaceuticals, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,000.00 General
10/01/2019 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $125.37 General
09/11/2019 Retrophin, Inc. (815) Thiola (Drug) Education In-kind items and services $1.54 General
Category: Kidney Stones
05/15/2019 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,074.50 General
Category: Immunology
04/04/2019 Amgen Inc. Parsabiv (Biological) Food and Beverage In-kind items and services $106.31 General
Category: Nephrology
12/20/2018 Alexion Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $77.39 General
12/20/2018 Alexion Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $37.06 General
12/11/2018 Alexion Pharmaceuticals, Inc. Honoraria Cash or cash equivalent $2,250.00 General
12/11/2018 Alexion Pharmaceuticals, Inc. Honoraria Cash or cash equivalent $2,000.00 General
12/08/2018 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $124.80 General
11/30/2018 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $96.76 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 14 804 1,267 $353,886 $114,989
2022 14 876 1,355 $385,251 $131,651
2021 18 1,022 1,552 $492,535 $183,440
2020 20 1,059 4,874 $508,354 $162,512
Total Patients
3,761
Total Services
9,048
Medicare Billing
$592,592
Procedure Codes
66

All Medicare Procedures & Services

66 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2023 16 103 $70,967 $27,596 38.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 267 372 $95,604 $25,196 26.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 153 361 $61,731 $21,879 35.4%
90966 Home dialysis services per month (20 years or older) Office 2023 12 51 $29,427 $11,247 38.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 68 68 $27,064 $8,210 30.3%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 75 77 $25,487 $7,692 30.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 30 41 $14,104 $3,763 26.7%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 24 30 $7,350 $2,742 37.3%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 18 18 $9,630 $2,264 23.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 32 32 $5,600 $1,971 35.2%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 28 30 $2,820 $1,145 40.6%
90935 Hemodialysis procedure with physician evaluation Facility 2023 17 20 $3,500 $1,097 31.3%
81002 Urinalysis, manual test Office 2023 38 38 $342.00 $129.58 37.9%
81003 Automated urinalysis test Office 2023 26 26 $260.00 $57.20 22.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 265 380 $97,529 $33,376 34.2%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2022 20 114 $78,546 $30,814 39.2%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 178 361 $61,731 $19,663 31.9%
90966 Home dialysis services per month (20 years or older) Office 2022 11 57 $32,889 $12,516 38.1%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 54 55 $29,362 $8,283 28.2%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 67 69 $22,839 $7,059 30.9%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 46 61 $14,945 $4,826 32.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 28 35 $12,040 $4,184 34.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 35 35 $13,930 $3,984 28.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 33 33 $5,775 $1,954 33.8%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 53 61 $5,734 $1,823 31.8%

About Dr. David Somerman, DO

Dr. David Somerman, DO is a Student in an Organized Health Care Education/Training Program healthcare provider based in Lancaster, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1255586178.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Somerman, DO has received a total of $44,139 in payments from pharmaceutical and medical device companies, with $117.01 received in 2024. These payments were reported across 127 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($22,187).

As a Medicare-enrolled provider, Somerman has provided services to 3,761 Medicare beneficiaries, totaling 9,048 services with total Medicare billing of $592,592. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.

Practice Information

Products in Payments

  • SOLIRIS (Drug) $27,581
  • Ultomiris (Drug) $1,313
  • FARXIGA (Drug) $125.01
  • Veltassa (Drug) $124.99
  • Parsabiv (Biological) $106.31
  • Renal - Non Product Related (Biological) $92.43
  • AURYXIA (Drug) $51.00
  • TAVNEOS (Drug) $31.02
  • JYNARQUE (Drug) $29.98
  • LOKELMA (Drug) $17.14
  • XARELTO (Drug) $15.13
  • (815) Thiola (Drug) $1.54

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Lancaster